Filed in archive
Diagnostics, Methodologies and Instrumentation
, Drugs, Vaccines and Therapeutics
by ruth on April 23, 2007
The researchers examined tumor tissue from 55 patients with squamous cell carcinoma of the nasopharynx, otherwise known as nasopharyngeal cancer. All patients had been treated by radiation therapy and follow-up was conducted for 10 years. The investigators found that rates of early recurrence (within five years) were significantly higher for individuals with high levels of SULF2 in the tumor (expressed in more than 10 percent of cancer cells). These same individuals were much more likely to die within 10 years.
SULF2 may thus pose an implication on the way individual nasopharyngeal cancer patients are treated. The enzyme also appears to be a factor in liver cancer. More details from the Mayo Clinic news release.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/65190
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Endosulfatase Enzyme Predicts Nasopharyngeal Cancer Survival and Recurrence Rates:
|
Rating: 9.00 out of 6 vote(s) cast.
|
Response from:
Trusted.MD Network
The American Cancer Society (ACS) has launched an online video community called SharingHope.tv.
A lot like YouTube, but the essence is that, it is a venue where cancer patients, survivors and their families can share their stories, triumphs, as well as
Response from:
Trusted.MD Network
April will be over soon, but i still would like to mention that April is Cancer Control Month.
© pingnews.com
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
